Accord Logo

Intended for UK patients and members of the public

SmPC- Tenofovir disoproxil Accordpharma 245 mg Film-coated Tablets: Change history

  • To update section 4.4 and 4.8 of SmPC and sections 2 and 4 of the leaflet in line with the reference product (Viread 245 mg film-coated tablets; EMA procedure number: EMEA/H/C/000419; MAH: Gilead Science International limited, Ireland).

     

    Additionally, section 4.2 of the SmPC has been updated with editorial changes in line with the reference product.

    • Changes: (Updated: 05 Nov 2024)

      To update section 4.4 and 4.8 of SmPC and sections 2 and 4 of the leaflet in line with the reference product (Viread 245 mg film-coated tablets; EMA procedure number: EMEA/H/C/000419; MAH: Gilead Science International limited, Ireland).

       

      Additionally, section 4.2 of the SmPC has been updated with editorial changes in line with the reference product.

    • Changes: (Updated: 20 Nov 2023)

      Description of update: Renewal. Renewal date: 08/11/2023 (Common renewal date: 01/10/2023).

      SmPC Sections updated: Section 4.4 (formatting only) and 10.

    • Changes: (Updated: 09 Aug 2023)

      Type IB: C.I.2. a) Implementation of change(s) for which no new additional data is required to be submitted by the MAH

      - Update SmPC and PIL in-line with the text of reference product Viread 245 mg film-coated tablets (Procedure number: EMEA/H/C/000419)

    • Changes: (Updated: 29 Jun 2023)

      Description of update: To update SmPC section 4.8 and leaflet section 4 to implement the wording agreed by the PRAC  following the outcome of the PSUSA procedure  (PSUSA/00010751/202203).

      SmPC sections updated: 4.8, 10.

    • Changes: (Updated: 09 Mar 2023)

      Initial upload

    View product information as a: